Utah Medical Products Inc. (UTMD)
NASDAQ: UTMDHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
UTMD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $198.01M
- P/E (TTM)
- 20.81
- EPS (TTM)
- $3.34
- Dividend yield
- 1.78% ($1.24)
- Ex-dividend date
- Dec 17, 2026
- 52-week range
- 53.80 – 76.89
- Day range
- 69.49 – 71.67
- Volume / Avg
- 29.99K / 33.70K
- Beta
- —
- Shares outstanding
- 2.85M
- Next earnings
- Jan 28, 2027
52-week range
UTMD stock today
On Nov 20, UTMD ended the session at $69.49, shedding $1.47 (2.07%), versus the S&P 500's 3.70% decline. At this level, UTMD sits in the middle of its 52-week range of $53.80 to $76.89: 9.6% below the high, set on Sep 22, 2026 and 29.2% above the low. UTMD is up 24.2% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 26.0%.
Utah Medical Products trades at 20.8x its trailing twelve-month earnings per share of $3.34. Utah Medical Products's next earnings report is expected on Jan 28, 2027. Utah Medical Products pays an annual dividend of $1.24 per share, a 1.78% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Utah Medical Products
Company profileUtah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Kevin L. Cornwell
- Headquarters
- Midvale, UT
- Employees
- 140
- Website
- utahmed.com
Financial highlights
Full financialsIn fiscal 2025, Utah Medical Products generated $38.5 million in revenue, down 5.8% from fiscal 2024, its first annual decline since 2024. Net income was $11.3 million (-18.7% year over year), for a net margin of 29.3% versus a median of 31.5% in the prior 5 years. Gross margin was 57.1% (down from 59.0%) and operating margin 29.6%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $38.52M | $40.90M | $50.22M | $52.28M | $49.05M |
| Growth | -5.83% | -18.56% | -3.93% | +6.58% | +16.30% |
| Net income | $11.29M | $13.87M | $16.64M | $16.47M | $14.79M |
| EPS (diluted) | $3.48 | $3.96 | $4.57 | $4.52 | $4.04 |
Earnings
Earnings history- Next report
- Jan 28, 2027
- Last reported (Sep/2026)
- Oct 22, 2026
- EPS actual vs est.
- $0.88 vs —
Dividends
Dividend history- Annual dividend
- $1.24
- Dividend yield
- 1.78%
- Last payment
- $0.315
- Ex-dividend date
- Dec 17, 2026
- Pay date
- Jan 5, 2027
UTMD news
All UTMD newsUtah Medical Products peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PDEXPro-Dex Inc. | 63.00 | -0.77% | $201.60M | vs UTMD |
| KTWOK2 Capital Acquisition Corporation Class A | 10.13 | 0.00% | $203.02M | vs UTMD |
| ANIKAnika Therapeutics Inc. | 13.23 | -0.38% | $177.22M | vs UTMD |
| CLPTClearPoint Neuro Inc. | 6.91 | -5.47% | $221.49M | vs UTMD |
| PROFProfound Medical Corp. | 6.38 | -3.19% | $233.68M | vs UTMD |
| OSUROraSure Technologies Inc. | 3.46 | -4.16% | $238.90M | vs UTMD |
| OFIXOrthofix Medical Inc. | 6.07 | -4.26% | $247.41M | vs UTMD |
| SSIISS Innovations International Inc. | 1.27 | -0.78% | $254.86M | vs UTMD |
Indexes, lists and sector
Utah Medical Products stock FAQ
What is Utah Medical Products's stock price today?
UTMD last traded at $69.49 as of Nov 20, 4:00 PM EST, down 2.07% on the day. Prices are delayed at least 15 minutes.
Does Utah Medical Products pay a dividend?
Yes. Utah Medical Products pays $1.24 per share annually, a 1.78% yield. The most recent dividend of $0.315 had an ex-dividend date of Dec 17, 2026.
When is Utah Medical Products's next earnings date?
Utah Medical Products is expected to report earnings on Thursday, January 28, 2027.
What is UTMD's P/E ratio?
UTMD trades at a trailing P/E ratio of 20.81.
Who is Utah Medical Products's CEO?
Mr. Kevin L. Cornwell is the chief executive officer of Utah Medical Products Inc., which has about 140 employees.
What is the UTMD 52-week high?
The 52-week high for UTMD is $76.89 and the 52-week low is $53.80. The stock is currently 9.6% below its high.